Anxiety · adults with tinnitus
1 finding from 1 review
Health‐related quality of life · adults with tinnitus
1 finding from 1 review
Negatively biased interpretations of tinnitus · adults with tinnitus
1 finding from 1 review
Other adverse effects · adults with tinnitus
1 finding from 1 review
Outcomes at end of treatment · adults with tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Impact of tinnitus on quality of life · adults with tinnitus
1 finding from 1 review
Serious adverse effects · adults with tinnitus
CBT showed no clear difference in serious adverse effects compared with other experimental control (low certainty).
1 finding from 1 review
Depression at end of treatment · adults with tinnitus
1 finding from 1 review
Anxiety · adults with tinnitus
1 finding from 1 review
Serious adverse effects at end of treatment · adults with tinnitus
CBT showed no clear difference in serious adverse effects at end of treatment compared with no intervention/waiting list control (moderate certainty).
1 finding from 1 review
Health‐related quality of life at end of treatment · adults with tinnitus
1 finding from 1 review
Negatively biased interpretations of tinnitus · adults with tinnitus
1 finding from 1 review
Other adverse effects · adults with tinnitus
1 finding from 1 review
Depression at end of treatment · adults with tinnitus
1 finding from 1 review
Anxiety · adults with tinnitus
1 finding from 1 review
Health‐related quality of life · adults with tinnitus
1 finding from 1 review
Negatively biased interpretations of tinnitus · adults with tinnitus
1 finding from 1 review
Other adverse effects · adults with tinnitus
1 finding from 1 review
Outcomes at end of treatment · adults with tinnitus
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Progression‐free survival (PSF) · Treatment‐naïve metastatic renal cell carcinoma (any cell type)
Sorafenib showed no clear difference in progression‐free survival (absolute effect size estimates based on… compared with sunitinib (targeted agent versus targeted agent) (low certainty).
1 finding from 1 review